line) agent but not against both these drugs simultaneously. XDR-TB is defined as TB resistant to RMP and INH (MDR-TB) with additional resistance to second line anti-TB drugs i.e. to any FLQs, and to at least one of the three injectable second-line drugs (ISL) naming amikacin, kanamycine and capreomycin. The prevalence of XDR-TB is 9.5% worldwide. Treatment of XDR-TB is complicated, as it requires the use of secondline drugs that are less effective and more toxic, thus demanding longer treatment duration. Detection of pre-XDR-TB cases among MDR-TB patients is an important step in the prevention of treatment failure of MDR-TB and in addition, it helps to take appropriate measures to halt the progression towards XDR-TB.
Pre XDR and XDR tuberculosis (TB) has become a serious threat to global TB control due to difficulties in Early diagnosis and treatment, and the associated high costs. (1) . Early detection of people with MDR-TB is one of the major bottlenecks in tackling this epidemic. Of the 480 000 MDR-TB cases estimated to have occurred in 2014, only about a quarter -123 000were detected and reported to national authorities. (2) In May 2016, WHO issued new recommendations on the use of a rapid diagnostic testa line probe assay to detect resistance to second-line anti-TB drugs (SL-LPA) (3). WHO recommends this rapid diagnostic test for identifying those MDR-or rifampicin-resistant TB patients who can be placed on the shorter MDR-TB regimen. (4) The results of this test will also be critical in placing patients on targeted conventional MDR-TB regimens with improved outcomes.
In India the rate of MDR and XDR TB infections has been steadily increasing (19) due to multiple incomplete treatment regimens and poor infection control practices. rapid, reliable, and accurate methods for the identification and detection of drug resistance in M. tuberculosis strains is necessary for adequate patient management, leading to improved outcomes, a reduction of infectiousness, (8) 
Materials and Methods
Total 700 samples (Sputum or Culture isolate) of known MDR TB were included in this study during the period of April19 to June 19.Clinical specimens are processed using the NALC/NaOH method as per universal Guideline. The MTBDRsl test is based on the DNA•STRIP technology. The whole procedure is divided into three steps: (i) DNA extraction from decontaminated sputum specimens or cultured material (solid/liquid medium)the necessary reagents are included in the kit, (ii) a multiplex amplification with biotinylated primers, and (iii) a reverse hybridization. All reagents needed for amplification, such as polymerase and primers, are included in the Amplification Mixes A and B (AM-A and AM-B) and are optimized for this test. The membrane strips are coated with specific probes complementary to the amplified nucleic acids. After chemical denaturation, the single stranded amplicons bind to the probes (hybridization). Highly specific binding of complementary DNA strands is ensured by stringent conditions which result from the combination of buffer composition and a certain temperature. Thus the probes reliably discriminate several sequence variations in the gene regions examined. The streptavidinconjugated alkaline phosphatase binds to the amplicons' biotin via the streptavidin moiety. Finally, the alkaline phosphatise transforms an added substrate into a dye which becomes visible on the membrane strips as a colored precipitate. A template ensures the easy and fast interpretation of the banding pattern obtained.
Results and Discussion
Total 700 MDR sputum Samples were tested, out of these 143(20.42%) pre XDR (Resistant to either Floroquionolonesorone of injectable second line) and 23 (3.2%)s XDR were found. Early screening of Pre XDR conditions is helpful for patients of MDR status to choose the proper Antibiotic regimen to prevent any spread of infectiousness and preventing patient for going toward XDR conditions. In XDR patient it will be helpful for better patient management by choosing proper line of management preventing spread to community ( Table 1 and 2).
In conclusions, MDRSl version 2 is rapid, reliable, and accurate Screening method for the identification and detection of Second line drug resistance in M. tuberculosis strains. Early detection of Pre XDR and XDR status helps to manage the tuberculosis patient by helping in deciding line of treatment. Liquid culture DST is always required for confirmation of resistance in positive cases. As liquid culture takes long time, MDRsl -2 reduce the time for diagnosis of susceptible group and helping in reducing infectivity.
